Alzheimer Drug Found Ineffective For FTD Patients
I’ve written in the past about the dangers that the off-label use of prescription drugs can present. In this instance, the use of the Alzheimer’s drug memantine for patients with frontotemporal dementia has not resulted in any severe negative side effects, but unfortunately a recent study also definitively found that it does not provide a benefit.
In the study, some patients were given a placebo while others took memantine. The drug was so widely accepted as an optimistic treatment option that patients were hesitant to agree to the study where they might be given a placebo instead. But, there was no significant recovery in either group and some patients taking memantine actually showed a faster decline in some cognitive tests than those in the placebo group.
You can read more about the details of the study in Eleanor McDermid’s article at Medical Daily.